Pumeirui Biotechnology
The AI engine Fit Assessment
BetaPumeirui leverages machine learning and innovative algorithms to enhance drug discovery, focusing on expanding therapeutics and optimizing the development process.
Blurb
Pumeirui Biotechnology is a developer of drug discovery algorithm platforms for improving the efficiency of drug development.
HQ Location
Changzhou (China)
Founded
2020
Employees
11 - 50
Total funding raised
Not available
Last Funding Event
Pre-Seed, November 29, 2021
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Drug Discovery Optimization
Developer of algorithm tool designed for innovative drug discovery. The company develops algorithms to predict the structure of biological macromolecule complexes, committing to accelerating targeted cancer therapies by leveraging artificial intelligence technology